Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  ConvaTec Group    CTEC   GB00BD3VFW73

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
10/10/2017 10/11/2017 10/12/2017 10/13/2017 10/16/2017 Date
281.7(c) 279.4(c) 280.9(c) 279.3(c) 205 Last
3 763 623 3 086 118 2 594 660 2 366 070 41 638 055 Volume
-0.81% -0.82% +0.54% -0.57% -26.60% Change
More quotes
Financials ($)
Sales 2017 1 777 M
EBIT 2017 420 M
Net income 2017 197 M
Debt 2017 1 470 M
Yield 2017 1,57%
Sales 2018 1 900 M
EBIT 2018 476 M
Net income 2018 274 M
Debt 2018 1 195 M
Yield 2018 1,99%
P/E ratio 2017 33,16
P/E ratio 2018 24,25
EV / Sales2017 4,90x
EV / Sales2018 4,44x
Capitalization 7 240 M
More Financials
Company
ConvaTec Group Plc is a holding company engages in medical business.Its activities include development, manufacture and sales of medical products and technologies related to therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy... 
More about the company
Surperformance© ratings of ConvaTec Group
Trading Rating : Investor Rating :
More Ratings
Latest news on CONVATEC GROUP
06:06p Miners provide foundation for FTSE while ConvaTec plummets
02:21p CONVATEC : Investors smash stocks which fail to meet earnings mark
10:45a CONVATEC : slashes revenue growth outlook, shares slump
09:50a CONVATEC : FY2017 guidance and third quarter update
08:10a CONVATEC : FY 2017 guidance and third quarter update 16 October 2017
09/28 CONVATEC : Talks focus on stoma support
09/19 CONVATEC : GentleCath Glide and me+ Launches in Europe
09/09 CONVATEC : MTS Health Investors, LLC Completes Sale of Woodbury Holdings
08/21 CONVATEC : Executive Committee 22/08/2017 21 August 2017
08/15 CONVATEC : appoints two Non-Executive Directors 14 August 2017
More news
Sector news : Specialty & Advanced Pharmaceuticals
06:09pDJDaimler Reshapes Company to Meet Challenges of Changing Industry -- Update
03:29p ASTRAZENECA : Pharma and medtech industries prepare for hard Brexit
10/14DJBAYER : Unloads Assets to Aid Deal -- WSJ
10/13 GLAXOSMITHKLINE : shingles vaccine gets approval in Canada
10/13 ASPEN PHARMACARE : UK anti-trust regulator investigates South Africa's Aspen Pha..
More sector news : Specialty & Advanced Pharmaceuticals
Latest Tweets
05:55pEurope closes mixed with Spain's IBEX down on Catalonia crisis; ConvaTec down..
1
04:48pFTSE 100 movers: Miners rally as copper prices surge; Convatec crumbles on wa.. 
03:57pEurope edges higher but Spain stocks slide on Catalonia crisis; ConvaTec down..
6
02:45pThe wider market implications of today's profits warning from medical devices.. 
02:25pConvaTec loses a fifth of its value on sales warning
2
More tweets
Qtime:34
News from SeekingAlpha
03/31 SNIPPET ROUNDUP : Novartis Meets CAR-T Filing Deadline, Numab Snares Ono
Chart CONVATEC GROUP
Duration : Period :
ConvaTec Group Technical Analysis Chart | CTEC | GB00BD3VFW73 | 4-Traders
Technical analysis trends CONVATEC GROUP
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 4,10 $
Spread / Average Target 11%
EPS Revisions
Managers
NameTitle
Paul Moraviec Chief Executive Officer & Director
Christopher Charles Gent Non-Executive Chairman
Michael Sgrignari Executive Vice President-Global Operations
Nigel Clerkin Chief Financial Officer & Director
Frank M. Schulkes Chief Financial Officer-Designate
Sector and Competitors
1st jan.Capitalization (M$)
CONVATEC GROUP19.41%7 227
ABBVIE44.79%144 537
MERCK KGAA-2.83%14 717
KYOWA HAKKO KIRIN CO LTD22.44%10 210
JAZZ PHARMACEUTICALS PLC29.67%8 492
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD29.42%5 435